Related Experiment Video
Updated: Dec 28, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
p62 Suppressed VK3-induced Oxidative Damage Through Keap1/Nrf2 Pathway In Human Ovarian Cancer Cells
Mei-Hui Xia1, Xiao-Yu Yan2, Lei Zhou3
1Department of Obstetrics, the First Bethune Hospital of Jilin University, Changchun, Jilin, China.
Abstract:
Imbalance of redox homeostasis may be responsible for the resistance of cancer to chemotherapy. Currently, increasing studies demonstrated that vitamin K3 (VK3), which promoted the production of ROS, had potential to be developed as an anti-tumor agent. We found SKOV3/DDP cells with high levels of p62 were insensitive to VK3 compared with SKOV3 cells. Furthermore, Nrf2 downstream antioxidant genes such as HO-1(heme oxygenase 1) and NQO1 (NAD (P) H: quinone oxidoreductase 1) were upregulated in SKOV3/DDP cells with VK3 treatment, which indicated VK3 activated Nrf2 signaling in SKOV3/DDP cells. Moreover, co-localization of p62 and Keap1 was also observed. Suppression of p62 expression increased the apoptosis induced by VK3, and the expression of Nrf2, HO-1 and NQO1 were all downregulated in SKOV3/DDP cells. Our results suggested that overexpressed p62 may protect cells from oxidative damage caused by VK3 through activating Keap1/Nrf2 signaling in ovarian cancer.
Insights
Overexpressed p62 protein protects ovarian cancer cells from vitamin K3 (VK3) induced oxidative damage by activating the Keap1/Nrf2 signaling pathway, suggesting a new therapeutic target.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Redox homeostasis imbalance is implicated in chemotherapy resistance in cancer.
- Vitamin K3 (VK3) shows potential as an anti-tumor agent by promoting reactive oxygen species (ROS) production.
Purpose of the Study:
- To investigate the role of p62 in mediating resistance to VK3 in ovarian cancer cells.
- To elucidate the underlying molecular mechanisms involving the Keap1/Nrf2 signaling pathway.
Main Methods:
- Comparison of VK3 sensitivity between SKOV3 and SKOV3/DDP ovarian cancer cells with differing p62 levels.
- Analysis of Nrf2 downstream antioxidant gene expression (HO-1, NQO1) following VK3 treatment.
- Investigation of p62 and Keap1 co-localization.
- Assessment of apoptosis and gene expression changes upon p62 suppression.
Main Results:
- SKOV3/DDP cells with high p62 levels exhibited insensitivity to VK3 compared to SKOV3 cells.
- VK3 treatment upregulated Nrf2 downstream antioxidant genes (HO-1, NQO1) in SKOV3/DDP cells, indicating Nrf2 pathway activation.
- Co-localization of p62 and Keap1 was observed.
- Suppression of p62 enhanced VK3-induced apoptosis and downregulated Nrf2, HO-1, and NQO1 expression.
Conclusions:
- Overexpressed p62 protects ovarian cancer cells against VK3-induced oxidative stress.
- The protective effect is mediated through the activation of the Keap1/Nrf2 signaling pathway.
- Targeting p62 may represent a novel strategy to overcome VK3 resistance in ovarian cancer.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
